Published on: Jan 29, 2018 at Business Insider

Daiichi Sankyo Presents Updated Data for DS-8201 in Patients with HER2-Expressing Gastric Cancer at ASCO 2018 Gastrointestinal Cancers Symposium

By : Business Insider

Encouraging phase 1 results were shared at ASCO for DS-8201 (an antibody drug conjugate) treatment for HER2-positive gastric cancer. 

Read More
SHARE